๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cellular aspects of the action of cytosine arabinoside

โœ Scribed by Valeriote, Fred


Publisher
John Wiley and Sons
Year
1982
Tongue
English
Weight
984 KB
Volume
10
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

โœฆ Synopsis


The cellular effects of Ara-C are reviewed including its S-phase sensitivity, its proliferative-dependent cytotoxicity and progression delay effects which result in unbalance growth. Both direct and indirect cytotoxic mechanisms are discussed.

The impact of such cellular information on the scheduling of Ara-C is presented with regard to normal and tumor cell population cytotoxicity. Based on these data a therapeutic rationale is presented.

Key words phase-specific, cell kinetics, drug scheduling, progression delay, therapeutic rationale


๐Ÿ“œ SIMILAR VOLUMES


Studies on the mechanism of action of cy
โœ Kufe, D. W. ;Major, P. P. ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 944 KB

We have demonstrated that Ara-C incorporates in leukemic cell DNA and that the extent of this incorporation correlates significantly with loss of clonogenic survival. This relationship between formation of (Ara-C)DNA and cytotoxicity is also obtained in the presence of modulating agents such as thym

Enzymology of cytosine arabinoside
โœ Cheng, Yung-Chi ;Capizzi, Robert L. ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 308 KB

The enzymes responsible for the metabolism of Ara-C and its metabolites in human cells are described. The relevance of the properties of those enzymes to the action of Ara-C is discussed.

Biochemical pharmacology of cytosine ara
โœ Momparler, Richard L. ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 268 KB

Cytosine arabinoside (Ara-C) is a very potent inhibitor of DNA synthesis in mammalian cells. This inhibition does not appear to be due to the direct inhibition of DNA polymerase by Ara-CTP (triphosphate of Ara-C) because it is a very weak competitive inhibitor of this enzyme. The inhibition of DNA s

Cytosine arabinoside in the management o
โœ T. S. Ganesan; M. J. Barnett; R. J. Amos; E. M. Piall; G. W. Aherne; A. Man; T. ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 254 KB

A Phase I1 study of high dose cytosine arabinoside (ara-C) with different schedules in patients with recurrent acute myelogenous leukaemia (AML) and myeloid blast crisis of chronic myeloid leukaemia has been conducted at St. Bartholomew's Hospital. Ara-C was infused continuously for seven days at a

Cytosine arabinoside in acute leukemia o
โœ D. G. Traggis; A. Dohlwitz; L. Das; N. Jaffe; W. C. Moloney; T. C. Hall ๐Ÿ“‚ Article ๐Ÿ“… 1971 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 304 KB ๐Ÿ‘ 2 views